Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19

The most severe presentation of COVID-19 is characterized by a hyperinflammatory state attributed to the massive pro-inflammatory cytokine release, called “cytokine storm”. Several specific anti-inflammatory/immunosuppressive agents are being evaluated by ongoing clinical trials; however, there is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalamaga, Maria, Karampela, Irene, Mantzoros, Christos S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
COVID-19 in Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263254/
https://www.ncbi.nlm.nih.gov/pubmed/32497535
http://dx.doi.org/10.1016/j.metabol.2020.154282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263254/
https://www.ncbi.nlm.nih.gov/pubmed/32497535
http://dx.doi.org/10.1016/j.metabol.2020.154282

Ejemplares similares